Alpha Tau Overview
- Founded
- 2016
- Status
- Private
- Employees
- 90
- Latest Deal Type
- PIPE
- Latest Deal Amount
- $90M
- Investors
- 10
Alpha Tau General Information
Description
Developer of an alpha radiation cancer therapy designed to provide potent and conformal radiation treatment for solid cancer. The company's therapy utilizes alpha radiation that treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor, enabling physicians to treat small tumors and metastatic lesions that have several significant clinical advantages.
Contact Information
Website
www.alphatau.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Primary Office
- Kiryat Hamada 5
- Jerusalem 9777605
- Israel
+972 00-000-0000
Alpha Tau Timeline
Alpha Tau Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. PIPE | 08-Mar-2022 | $90M | 00000 | Completed | Clinical Trials - General | |
| 5. Reverse Merger | 08-Mar-2022 | 00000 | 000.00 | 000 | Completed | Clinical Trials - General |
| 4. Early Stage VC (Series B) | 13-Mar-2020 | 0000 | 000.00 | 00000 | Completed | Clinical Trials - General |
| 3. Early Stage VC (Series A) | 05-Sep-2018 | 000.00 | 000.00 | 00000 | Completed | Startup |
| 2. Early Stage VC | 19-Jul-2017 | Completed | Startup | |||
| 1. Angel (individual) | Completed | Startup |
Alpha Tau Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an alpha radiation cancer therapy designed to provide potent and conformal radiation treatment for solid ca
Therapeutic Devices
Jerusalem, Israel
90
As of 2022
00000
000000000
00000
00000000
ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
0000000000000
Hayward, CA
000
As of 0000
00000
0000
0000-00-00
00000000000
00000
00000000
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
00000000000 0000000
Morrisville, NC
0
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAlpha Tau Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RefleXion Medical | Venture Capital-Backed | Hayward, CA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 00000000 | Venture Capital-Backed | Morrisville, NC | 0 | 000.00 | 00000000000 | 000.00 |
| 0000000000 | Venture Capital-Backed | Groningen, Netherlands | 00 | 0000000000 | ||
| 000000 0000000 000 | Private Equity-Backed | Littleton, MA | 000 | 00000 | 0000000 0000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Cambridge, United Kingdom | 0 | 00.00 | 0000000000 0 | 00.00 |
Alpha Tau Patents
Alpha Tau Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210128945-A1 | Wet preparation of radiotherapy sources | Pending | 10-Oct-2019 | 0000000000 | |
| AU-2019370892-A1 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | Pending | 01-Nov-2018 | 0000000000 | |
| CA-3114299-A1 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | Pending | 01-Nov-2018 | 0000000000 | |
| EP-3873598-A1 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | Pending | 01-Nov-2018 | 0000000000 | |
| JP-2021519126-A | Controlled release of radionuclides | Pending | 02-Apr-2018 | A61K51/1282 |
Alpha Tau Executive Team (7)
Alpha Tau Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alan Adler | Alpha Tau | Board Member | 000 0000 |
| Gary Leibler | Shavit Capital | Board Member | 000 0000 |
| John Brown MD | Alpha Tau | Board Member | 000 0000 |
| Meir Jakobsohn | Alpha Tau | Board Member | 000 0000 |
| Michael Avruch | Alpha Tau | Board Member | 000 0000 |
Alpha Tau Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAlpha Tau Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Grand Decade | Corporation | Minority | 000 0000 | 000000 0 | |
| Healthcare Capital(Wilmington) | Special Purpose Acquisition Company (SPAC) | Minority | 000 0000 | 000000 0 | |
| Yozma Group Korea | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Das & Co. | Family Office | Minority | 000 0000 | 000000 0 | |
| Alan Patricof | Angel (individual) | Minority | 000 0000 | 000000 0 |
Alpha Tau Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000000 0000000 | Special Purpose Acquisition Company (SPAC) | Wilmington, DE | 0000 |